Caricamento...

Comparison of twice-daily vs once-daily deferasirox dosing in a gerbil model of iron cardiomyopathy

OBJECTIVE: Despite the availability of deferoxamine chelation therapy for more than 20 years, iron cardiomyopathy remains the leading cause of death in thalassemia major patients. Effective chelation of cardiac iron is difficult; cardiac iron stores respond more slowly to chelation therapy and requi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Otto-Duessel, Maya, Aguilar, Michelle, Nick, Hanspeter, Moats, Rex, Wood, John C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2007
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2892931/
https://ncbi.nlm.nih.gov/pubmed/17588475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2007.04.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !